Hua Medicine (02552) released its monthly return for the period ending 30 November 2025. Total authorized share capital remained at 2,000,000,000 ordinary shares, each with a par value of USD 0.001, amounting to USD 2,000,000 in aggregate.
The total number of issued shares stood at 1,056,605,016, with no change during the reporting period. Under the post-IPO share option scheme, 20,000,000 new share options were granted in November, raising the total outstanding share options from 59,289,669 to 79,289,669. No options were exercised, canceled, or lapsed during the month, and there was no change in treasury shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.